S. Q. Harper, M. A. Hauser, C. Dellorusso, D. Duan, R. W. Crawford et al., Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy, Nature Medicine, vol.8, issue.3, 2002.
DOI : 10.1038/nm0302-253

A. Goyenvalle, A. Babbs, J. Wright, V. Wilkins, D. Powell et al., Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping, Human Molecular Genetics, vol.21, issue.11, pp.2559-2571, 2012.
DOI : 10.1093/hmg/dds082

URL : https://academic.oup.com/hmg/article-pdf/21/11/2559/17255740/dds082.pdf

L. T. Bish, M. M. Sleeper, S. C. Forbes, B. Wang, C. Reynolds et al., Long-term Restoration of Cardiac Dystrophin Expression in Golden Retriever Muscular Dystrophy Following rAAV6-mediated Exon Skipping, Molecular Therapy, vol.20, issue.3, 2012.
DOI : 10.1038/mt.2011.264

A. Vulin, I. Barthelemy, A. Goyenvalle, J. L. Thibaud, C. Beley et al., Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping, Molecular Therapy, vol.20, issue.11, pp.2120-2133, 2012.
DOI : 10.1038/mt.2012.181

URL : http://doi.org/10.1038/mt.2012.181

L. Guiner, C. Montus, M. Servais, L. Cherel, Y. Francois et al., Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients, Molecular Therapy, vol.22, issue.11, pp.1923-1935, 2014.
DOI : 10.1038/mt.2014.151

L. Hir, M. Goyenvalle, A. Peccate, C. Precigout, G. Davies et al., AAV Genome Loss From Dystrophic Mouse Muscles During AAV-U7 snRNA-mediated Exon-skipping Therapy, Molecular Therapy, vol.21, issue.8, pp.1551-1558, 2013.
DOI : 10.1038/mt.2013.121

S. Lorain, D. A. Gross, A. Goyenvalle, O. Danos, J. Davoust et al., Transient Immunomodulation Allows Repeated Injections of AAV1 and Correction of Muscular Dystrophy in Multiple Muscles, Molecular Therapy, vol.16, issue.3, pp.541-547, 2008.
DOI : 10.1038/sj.mt.6300377

A. Aartsma-rus, I. Fokkema, J. Verschuuren, I. Ginjaar, J. Van-deutekom et al., Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations, Human Mutation, vol.7, issue.3, pp.293-299, 2009.
DOI : 10.1212/WNL.46.5.1347